|
ALG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40329999999789E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.400200E-02 |
| Normal-vs-Stage2 |
9.568400E-02 |
| Normal-vs-Stage3 |
2.55320000031034E-07 |
| Normal-vs-Stage4 |
1.611450E-04 |
| Stage1-vs-Stage2 |
5.682200E-01 |
| Stage1-vs-Stage3 |
1.005240E-04 |
| Stage1-vs-Stage4 |
6.277300E-03 |
| Stage2-vs-Stage3 |
5.121500E-02 |
| Stage2-vs-Stage4 |
1.009760E-01 |
| Stage3-vs-Stage4 |
8.892000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.06459999999575E-05 |
| Normal-vs-AfricanAmerican |
1.040550E-01 |
| Normal-vs-Asian |
1.443600E-01 |
| Caucasian-vs-AfricanAmerican |
4.350600E-01 |
| Caucasian-vs-Asian |
5.673200E-01 |
| AfricanAmerican-vs-Asian |
4.209600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.04630012723817E-10 |
| Normal-vs-Female |
9.205800E-01 |
| Male-vs-Female |
3.66500000348324E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.615950E-04 |
| Normal-vs-Age(41-60Yrs) |
1.857130E-03 |
| Normal-vs-Age(61-80Yrs) |
3.52909999999929E-05 |
| Normal-vs-Age(81-100Yrs) |
4.010200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.340980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.292600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.206400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.712800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.744800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.943200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.326600E-01 |
| Normal-vs-Grade 2 |
8.107600E-02 |
| Normal-vs-Grade 3 |
6.38960000000077E-05 |
| Normal-vs-Grade 4 |
8.02136135291676E-12 |
| Grade 1-vs-Grade 2 |
4.587200E-01 |
| Grade 1-vs-Grade 3 |
1.429630E-01 |
| Grade 1-vs-Grade 4 |
6.751300E-04 |
| Grade 2-vs-Grade 3 |
7.878600E-03 |
| Grade 2-vs-Grade 4 |
9.43859990165663E-10 |
| Grade 3-vs-Grade 4 |
2.033700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.518800E-01 |
| Normal-vs-ccB subtype |
5.88340487439609E-11 |
| ccA subtype-vs-ccB subtype |
1.08801856413265E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.988200E-04 |
| Normal-vs-N1 |
3.9071000002E-07 |
| N0-vs-N1 |
2.289600E-02 |
|
|
